Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 124

1.

Correction to: Assessing the volatile profile of carob tree (Ceratonia siliqua L.).

Krokou A, Stylianou M, Agapiou A.

Environ Sci Pollut Res Int. 2019 Apr 26. doi: 10.1007/s11356-019-05167-1. [Epub ahead of print]

PMID:
31028617
2.

Assessing the volatile profile of carob tree (Ceratonia siliqua L.).

Krokou A, Stylianou M, Agapiou A.

Environ Sci Pollut Res Int. 2019 Mar 27. doi: 10.1007/s11356-019-04664-7. [Epub ahead of print] Erratum in: Environ Sci Pollut Res Int. 2019 Apr 26;:.

PMID:
30919189
3.

Angiotensin-converting enzyme inhibitors may affect pulmonary function in lymphangioleiomyomatosis.

Steagall WK, Stylianou M, Pacheco-Rodriguez G, Moss J.

JCI Insight. 2019 Mar 7;4(5). pii: 126703. doi: 10.1172/jci.insight.126703. eCollection 2019 Mar 7.

4.

Main and side stream effects of electronic cigarettes.

Papaefstathiou E, Stylianou M, Agapiou A.

J Environ Manage. 2019 May 15;238:10-17. doi: 10.1016/j.jenvman.2019.01.030. Epub 2019 Mar 2.

PMID:
30836280
5.

Use of CT Imaging to Quantify Progression and Response to Treatment in Lymphangioleiomyomatosis.

Gopalakrishnan V, Yao J, Steagall WK, Avila NA, Taveira-DaSilva AM, Stylianou M, Chen MY, Moss J.

Chest. 2019 May;155(5):962-971. doi: 10.1016/j.chest.2019.01.004. Epub 2019 Jan 17.

PMID:
30660784
6.

Results from Australia's 2018 Report Card on Physical Activity for Children and Youth.

Schranz N, Glennon V, Evans J, Gomersall S, Hardy L, Hesketh KD, Lubans D, Ridgers ND, Straker L, Stylianou M, Tomkinson GR, Vella S, Ziviani J, Olds T.

J Phys Act Health. 2018 Nov 1;15(S2):S315-S317. doi: 10.1123/jpah.2018-0418. No abstract available.

PMID:
30475112
7.

Evasion of Immune Surveillance in Low Oxygen Environments Enhances Candida albicans Virulence.

Lopes JP, Stylianou M, Backman E, Holmberg S, Jass J, Claesson R, Urban CF.

MBio. 2018 Nov 6;9(6). pii: e02120-18. doi: 10.1128/mBio.02120-18.

8.

Distinct transcriptional response of Caenorhabditis elegans to different exposure routes of perfluorooctane sulfonic acid.

Stylianou M, Björnsdotter MK, Olsson PE, Ericson Jogsten I, Jass J.

Environ Res. 2019 Jan;168:406-413. doi: 10.1016/j.envres.2018.10.019. Epub 2018 Oct 18.

PMID:
30388497
9.

Laboratory Testing in Support of Surfactant-Alternating-Gas Foam Flood for NAPL Recovery from Shallow Subsurface.

Stylianou M, Lee JH, Kostarelos K, Voskaridou T.

Bull Environ Contam Toxicol. 2018 Dec;101(6):744-750. doi: 10.1007/s00128-018-2453-y. Epub 2018 Sep 25.

PMID:
30255234
10.

Assessment of Neutrophil Chemotaxis Upon G-CSF Treatment of Healthy Stem Cell Donors and in Allogeneic Transplant Recipients.

Thunström Salzer A, Niemiec MJ, Hosseinzadeh A, Stylianou M, Åström F, Röhm M, Ahlm C, Wahlin A, Ermert D, Urban CF.

Front Immunol. 2018 Sep 11;9:1968. doi: 10.3389/fimmu.2018.01968. eCollection 2018.

11.

Predictors of Rapid Aortic Root Dilation and Referral for Aortic Surgery in Marfan Syndrome.

Hoskoppal A, Menon S, Trachtenberg F, Burns KM, De Backer J, Gelb BD, Gleason M, James J, Lai WW, Liou A, Mahony L, Olson AK, Pyeritz RE, Sharkey AM, Stylianou M, Wechsler SB, Young L, Levine JC, Tierney ESS, Lacro RV, Bradley TJ; Pediatric Heart Network Investigators.

Pediatr Cardiol. 2018 Oct;39(7):1453-1461. doi: 10.1007/s00246-018-1916-6. Epub 2018 Jun 11.

12.

Design and rationale of the Fontan Udenafil Exercise Longitudinal (FUEL) trial.

Goldberg DJ, Zak V, Goldstein BH, McCrindle BW, Menon SC, Schumacher KR, Payne RM, Rhodes J, McHugh KE, Penny DJ, Trachtenberg F, Hamstra MS, Richmond ME, Frommelt PC, Files MD, Yeager JL, Pemberton VL, Stylianou MP, Pearson GD, Paridon SM; Pediatric Heart Network Investigators.

Am Heart J. 2018 Jul;201:1-8. doi: 10.1016/j.ahj.2018.03.015. Epub 2018 Apr 3. Review.

PMID:
29910047
13.

Converting environmental risks to benefits by using spent coffee grounds (SCG) as a valuable resource.

Stylianou M, Agapiou A, Omirou M, Vyrides I, Ioannides IM, Maratheftis G, Fasoula D.

Environ Sci Pollut Res Int. 2018 Dec;25(36):35776-35790. doi: 10.1007/s11356-018-2359-6. Epub 2018 Jun 2. Review.

PMID:
29860699
14.

Pseudomonas aeruginosa Regulated Intramembrane Proteolysis: Protease MucP Can Overcome Mutations in the AlgO Periplasmic Protease To Restore Alginate Production in Nonmucoid Revertants.

Delgado C, Florez L, Lollett I, Lopez C, Kangeyan S, Kumari H, Stylianou M, Smiddy RJ, Schneper L, Sautter RT, Smith D, Szatmari G, Mathee K.

J Bacteriol. 2018 Jul 25;200(16). pii: e00215-18. doi: 10.1128/JB.00215-18. Print 2018 Aug 15.

15.

The Effect of an Authentic Acute Physical Education Session of Dance on Elementary Students' Selective Attention.

Kulinna PH, Stylianou M, Dyson B, Banville D, Dryden C, Colby R.

Biomed Res Int. 2018 Feb 5;2018:8790283. doi: 10.1155/2018/8790283. eCollection 2018.

16.

Quantitative electroencephalography as a marker of cognitive fluctuations in dementia with Lewy bodies and an aid to differential diagnosis.

Stylianou M, Murphy N, Peraza LR, Graziadio S, Cromarty R, Killen A, O' Brien JT, Thomas AJ, LeBeau FEN, Taylor JP.

Clin Neurophysiol. 2018 Jun;129(6):1209-1220. doi: 10.1016/j.clinph.2018.03.013. Epub 2018 Apr 3.

17.

Rates of change in FEV1 and DLCO as potential indicators for mTOR inhibitor therapy in premenopausal lymphangioleiomyomatosis patients.

Taveira-DaSilva AM, Julien-Williams P, Jones AM, Stylianou M, Moss J.

Eur Respir J. 2018 Apr 19;51(4). pii: 1702258. doi: 10.1183/13993003.02258-2017. Print 2018 Apr.

PMID:
29519926
18.

Effect of beta-agonists on LAM progression and treatment.

Le K, Steagall WK, Stylianou M, Pacheco-Rodriguez G, Darling TN, Vaughan M, Moss J.

Proc Natl Acad Sci U S A. 2018 Jan 30;115(5):E944-E953. doi: 10.1073/pnas.1719960115. Epub 2018 Jan 16.

19.

An assessment of Australian school physical activity and nutrition policies.

Stylianou M, Walker JL.

Aust N Z J Public Health. 2018 Feb;42(1):16-21. doi: 10.1111/1753-6405.12751. Epub 2017 Dec 13.

PMID:
29235711
20.

Relationship of Echocardiographic Z Scores Adjusted for Body Surface Area to Age, Sex, Race, and Ethnicity: The Pediatric Heart Network Normal Echocardiogram Database.

Lopez L, Colan S, Stylianou M, Granger S, Trachtenberg F, Frommelt P, Pearson G, Camarda J, Cnota J, Cohen M, Dragulescu A, Frommelt M, Garuba O, Johnson T, Lai W, Mahgerefteh J, Pignatelli R, Prakash A, Sachdeva R, Soriano B, Soslow J, Spurney C, Srivastava S, Taylor C, Thankavel P, van der Velde M, Minich L; Pediatric Heart Network Investigators*.

Circ Cardiovasc Imaging. 2017 Nov;10(11). pii: e006979. doi: 10.1161/CIRCIMAGING.117.006979.

21.

High density lipoproteins and type 2 inflammatory biomarkers are negatively correlated in atopic asthmatics.

Barochia AV, Gordon EM, Kaler M, Cuento RA, Theard P, Figueroa DM, Yao X, Weir NA, Sampson ML, Stylianou M, Choy DF, Holweg CTJ, Remaley AT, Levine SJ.

J Lipid Res. 2017 Aug;58(8):1713-1721. doi: 10.1194/jlr.P077776. Epub 2017 Jun 27.

22.

A randomized, placebo-controlled, double-blinded, crossover trial of pioglitazone for severe asthma.

Kaler M, Barochia AV, Weir NA, Cuento RA, Stylianou M, Roth MJ, Filie AC, Vaughey EC, Nathan SD, Levine SJ.

J Allergy Clin Immunol. 2017 Dec;140(6):1716-1718. doi: 10.1016/j.jaci.2017.05.033. Epub 2017 Jun 15. No abstract available.

23.

Investigation of Phenols Activity in Early Stage Oxidation of Edible Oils by Electron Paramagnetic Resonance and 19F NMR Spectroscopies Using Novel Lipid Vanadium Complexes As Radical Initiators.

Drouza C, Dieronitou A, Hadjiadamou I, Stylianou M.

J Agric Food Chem. 2017 Jun 21;65(24):4942-4951. doi: 10.1021/acs.jafc.7b01144. Epub 2017 Jun 13.

PMID:
28582612
24.

Results of a phase I/II multi-center investigation of udenafil in adolescents after fontan palliation.

Goldberg DJ, Zak V, Goldstein BH, Chen S, Hamstra MS, Radojewski EA, Maunsell E, Mital S, Menon SC, Schumacher KR, Payne RM, Stylianou M, Kaltman JR, deVries TM, Yeager JL, Paridon SM; Pediatric Heart Network Investigators.

Am Heart J. 2017 Jun;188:42-52. doi: 10.1016/j.ahj.2017.02.030. Epub 2017 Mar 6.

25.

CA-125 in Disease Progression and Treatment of Lymphangioleiomyomatosis.

Glasgow CG, Pacheco-Rodriguez G, Steagall WK, Haughey ME, Julien-Williams PA, Stylianou MP, Gochuico BR, Moss J.

Chest. 2018 Feb;153(2):339-348. doi: 10.1016/j.chest.2017.05.018. Epub 2017 May 30.

26.

Long-Term Effect of Sirolimus on Serum Vascular Endothelial Growth Factor D Levels in Patients With Lymphangioleiomyomatosis.

Taveira-DaSilva AM, Jones AM, Julien-Williams P, Stylianou M, Moss J.

Chest. 2018 Jan;153(1):124-132. doi: 10.1016/j.chest.2017.05.012. Epub 2017 May 19.

27.

Phenol-Soluble Modulin α Peptide Toxins from Aggressive Staphylococcus aureus Induce Rapid Formation of Neutrophil Extracellular Traps through a Reactive Oxygen Species-Independent Pathway.

Björnsdottir H, Dahlstrand Rudin A, Klose FP, Elmwall J, Welin A, Stylianou M, Christenson K, Urban CF, Forsman H, Dahlgren C, Karlsson A, Bylund J.

Front Immunol. 2017 Mar 9;8:257. doi: 10.3389/fimmu.2017.00257. eCollection 2017.

28.

Synthesis of new photosensitive H2BBQ2+[ZnCl4]2-/[(ZnCl)2(μ-BBH)] complexes, through selective oxidation of H2O to H2O2.

Stylianou M, Hadjiadamou I, Drouza C, Hayes SC, Lariou E, Tantis I, Lianos P, Tsipis AC, Keramidas AD.

Dalton Trans. 2017 Mar 14;46(11):3688-3699. doi: 10.1039/c6dt04643f.

PMID:
28256650
29.

Aberrant SYK Kinase Signaling Is Essential for Tumorigenesis Induced by TSC2 Inactivation.

Cui Y, Steagall WK, Lamattina AM, Pacheco-Rodriguez G, Stylianou M, Kidambi P, Stump B, Golzarri F, Rosas IO, Priolo C, Henske EP, Moss J, El-Chemaly S.

Cancer Res. 2017 Mar 15;77(6):1492-1502. doi: 10.1158/0008-5472.CAN-16-2755. Epub 2017 Feb 15.

30.

Before-School Running/Walking Club and Student Physical Activity Levels: An Efficacy Study.

Stylianou M, van der Mars H, Kulinna PH, Adams MA, Mahar M, Amazeen E.

Res Q Exerc Sport. 2016 Dec;87(4):342-353. Epub 2016 Aug 22.

PMID:
27548614
31.

Before-school running/walking club: Effects on student on-task behavior.

Stylianou M, Kulinna PH, van der Mars H, Mahar MT, Adams MA, Amazeen E.

Prev Med Rep. 2016 Feb 1;3:196-202. doi: 10.1016/j.pmedr.2016.01.010. eCollection 2016 Jun.

32.

Why Machiavellianism Matters in Childhood: The Relationship Between Children's Machiavellian Traits and Their Peer Interactions in a Natural Setting.

Abell L, Qualter P, Brewer G, Barlow A, Stylianou M, Henzi P, Barrett L.

Eur J Psychol. 2015 Aug 20;11(3):484-93. doi: 10.5964/ejop.v11i3.957. eCollection 2015 Aug.

33.

Identification of Biological and Pharmaceutical Mast Cell- and Basophil-Related Targets.

Klein O, Ngo-Nyekel F, Stefanache T, Torres R, Salomonsson M, Hallgren J, Rådinger M, Bambouskova M, Campbell M, Cohen-Mor S, Dema B, Rose CG, Abrink M, Charles N, Ainooson G, Paivandy A, Pavlova VG, Serrano-Candelas E, Yu Y, Hellman L, Jensen BM, Van Anrooij B, Grootens J, Gura HK, Stylianou M, Tobio A, Blank U, Öhrvik H, Maurer M.

Scand J Immunol. 2016 Jun;83(6):465-72. doi: 10.1111/sji.12436. No abstract available.

34.

Jet A fuel recovery using micellar flooding: Design and implementation.

Kostarelos K, Lenschow SR, Stylianou MA, de Blanc PC, Mygind MM, Christensen AG.

Sci Total Environ. 2016 Sep 1;563-564:890-8. doi: 10.1016/j.scitotenv.2016.02.211. Epub 2016 Mar 25.

PMID:
27019952
35.

Aerial Oxidation of a V(IV)-Iminopyridine Hydroquinonate Complex: A Trap for the V(IV)-Semiquinonate Radical Intermediate.

Stylianou M, Drouza C, Giapintzakis J, Athanasopoulos GI, Keramidas AD.

Inorg Chem. 2015 Aug 3;54(15):7218-29. doi: 10.1021/acs.inorgchem.5b00571. Epub 2015 Jul 22.

PMID:
26200893
36.

Opportunistic pathogen Candida albicans elicits a temporal response in primary human mast cells.

Lopes JP, Stylianou M, Nilsson G, Urban CF.

Sci Rep. 2015 Jul 20;5:12287. doi: 10.1038/srep12287.

37.

Effect of fasting on the size of lymphangioleiomyomas in patients with lymphangioleiomyomatosis.

Taveira-DaSilva AM, Jones AM, Julien-Williams P, Shawker T, Glasgow CG, Stylianou M, Moss J.

Chest. 2015 Oct;148(4):1027-1033. doi: 10.1378/chest.15-0456.

38.

Design and rationale of a prospective, collaborative meta-analysis of all randomized controlled trials of angiotensin receptor antagonists in Marfan syndrome, based on individual patient data: A report from the Marfan Treatment Trialists' Collaboration.

Pitcher A, Emberson J, Lacro RV, Sleeper LA, Stylianou M, Mahony L, Pearson GD, Groenink M, Mulder BJ, Zwinderman AH, De Backer J, De Paepe AM, Arbustini E, Erdem G, Jin XY, Flather MD, Mullen MJ, Child AH, Forteza A, Evangelista A, Chiu HH, Wu MH, Sandor G, Bhatt AB, Creager MA, Devereux RB, Loeys B, Forfar JC, Neubauer S, Watkins H, Boileau C, Jondeau G, Dietz HC, Baigent C.

Am Heart J. 2015 May;169(5):605-12. doi: 10.1016/j.ahj.2015.01.011. Epub 2015 Feb 12.

39.

Legacy soil contamination at abandoned mine sites: making a case for guidance on soil protection.

Kostarelos K, Gavriel I, Stylianou M, Zissimos AM, Morisseau E, Dermatas D.

Bull Environ Contam Toxicol. 2015 Mar;94(3):269-74. doi: 10.1007/s00128-015-1461-4. Epub 2015 Jan 20.

PMID:
25600021
40.

Severity and outcome of cystic lung disease in women with tuberous sclerosis complex.

Taveira-DaSilva AM, Jones AM, Julien-Williams P, Yao J, Stylianou M, Moss J.

Eur Respir J. 2015 Jan;45(1):171-80. doi: 10.1183/09031936.00088314. Epub 2014 Dec 23.

41.

Atenolol versus losartan in children and young adults with Marfan's syndrome.

Lacro RV, Dietz HC, Sleeper LA, Yetman AT, Bradley TJ, Colan SD, Pearson GD, Selamet Tierney ES, Levine JC, Atz AM, Benson DW, Braverman AC, Chen S, De Backer J, Gelb BD, Grossfeld PD, Klein GL, Lai WW, Liou A, Loeys BL, Markham LW, Olson AK, Paridon SM, Pemberton VL, Pierpont ME, Pyeritz RE, Radojewski E, Roman MJ, Sharkey AM, Stylianou MP, Wechsler SB, Young LT, Mahony L; Pediatric Heart Network Investigators.

N Engl J Med. 2014 Nov 27;371(22):2061-71. doi: 10.1056/NEJMoa1404731. Epub 2014 Nov 18.

42.

Sustained effects of sirolimus on lung function and cystic lung lesions in lymphangioleiomyomatosis.

Yao J, Taveira-DaSilva AM, Jones AM, Julien-Williams P, Stylianou M, Moss J.

Am J Respir Crit Care Med. 2014 Dec 1;190(11):1273-82. doi: 10.1164/rccm.201405-0918OC.

43.

Novel high-throughput screening method for identification of fungal dimorphism blockers.

Stylianou M, Uvell H, Lopes JP, Enquist PA, Elofsson M, Urban CF.

J Biomol Screen. 2015 Feb;20(2):285-91. doi: 10.1177/1087057114552954. Epub 2014 Oct 3.

PMID:
25281739
44.

Retrospective review of combined sirolimus and simvastatin therapy in lymphangioleiomyomatosis.

Taveira-DaSilva AM, Jones AM, Julien-Williams PA, Stylianou M, Moss J.

Chest. 2015 Jan;147(1):180-187. doi: 10.1378/chest.14-0758.

45.

EDTA chelation therapy alone and in combination with oral high-dose multivitamins and minerals for coronary disease: The factorial group results of the Trial to Assess Chelation Therapy.

Lamas GA, Boineau R, Goertz C, Mark DB, Rosenberg Y, Stylianou M, Rozema T, Nahin RL, Terry Chappell L, Lindblad L, Lewis EF, Drisko J, Lee KL.

Am Heart J. 2014 Jul;168(1):37-44.e5. doi: 10.1016/j.ahj.2014.02.012. Epub 2014 Apr 2.

46.

Oral high-dose multivitamins and minerals after myocardial infarction: a randomized trial.

Lamas GA, Boineau R, Goertz C, Mark DB, Rosenberg Y, Stylianou M, Rozema T, Nahin RL, Lindblad L, Lewis EF, Drisko J, Lee KL; TACT (Trial to Assess Chelation Therapy) Investigators.

Ann Intern Med. 2013 Dec 17;159(12):797-805.

47.

Antifungal application of nonantifungal drugs.

Stylianou M, Kulesskiy E, Lopes JP, Granlund M, Wennerberg K, Urban CF.

Antimicrob Agents Chemother. 2014;58(2):1055-62. doi: 10.1128/AAC.01087-13. Epub 2013 Nov 25.

48.

Sirolimus decreases circulating lymphangioleiomyomatosis cells in patients with lymphangioleiomyomatosis.

Cai X, Pacheco-Rodriguez G, Haughey M, Samsel L, Xu S, Wu HP, McCoy JP, Stylianou M, Darling TN, Moss J.

Chest. 2014 Jan;145(1):108-112. doi: 10.1378/chest.13-1071.

49.

Molybdenum(VI) coordination chemistry of the N,N-disubstituted bis(hydroxylamido)-1,3,5-triazine ligand, H2bihyat. Water-assisted activation of the Mo(VI)═O bond and reversible dimerization of cis-[Mo(VI)O2(bihyat)] to [Mo(VI)2O4(bihyat)2(H2O)2].

Stylianou M, Nikolakis VA, Chilas GI, Jakusch T, Vaimakis T, Kiss T, Sigalas MP, Keramidas AD, Kabanos TA.

Inorg Chem. 2012 Dec 17;51(24):13138-47. doi: 10.1021/ic301282q. Epub 2012 Dec 5.

PMID:
23214947
50.

Expression and distribution of aggrecanases in human larynx: ADAMTS-5/aggrecanase-2 is the main aggrecanase in laryngeal carcinoma.

Filou S, Stylianou M, Triantaphyllidou IE, Papadas T, Mastronikolis NS, Goumas PD, Papachristou DJ, Ravazoula P, Skandalis SS, Vynios DH.

Biochimie. 2013 Apr;95(4):725-34. doi: 10.1016/j.biochi.2012.10.022. Epub 2012 Nov 3.

PMID:
23131589

Supplemental Content

Loading ...
Support Center